December 2019

Admac started its operations in 1985 with the mission to spread quality healthcare everywhere. Our endeavor is to ensure the availabilitty of world class quality medicines at affordable prices across the globe. We are com- mittedto work towards a healthier & happier world. From clinicalto commercial services, we focus on the right resources to provide the highest level of service and quality while applying innovative solutions to satisfy customers.

Tirupati Group is one of the largest and fastest growing company, providing end-to-end solutions from research to product launch with multiple manufacturing facilities based out of Paonta Sahib, a serene town based on the foothills of Himachal Pradesh, India. The group was founded way back in 2005 and has already reached a significant size of Rs. 500 Cr (approx. 80 MN USD).

Headquartered in India, Strides Pharma Science Limited (Formerly Strides Shasun Limited) is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world's largest manufacturers of soft gelatin capsules. With world-class manufacturing facilities, an innovative R&D hub in Bangalore and a robust commercial platform to market products globally, Strides has earned a reputation for building and scaling profitable businesses in a short span of time.

Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within Haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 33,300 employees in 75 countries, and markets its products in more than 190 countries Novo Nordisk’s B shares are listed on NASDAQ OMX Copenhagen (Novo-B).

Post : Regulatory Affairs Associate Analyst

Orphan drugs are medicinal products intended for diagnosis, prevention or treatment of life-threatening or very serious diseases or disorders that are rare. In USA, the Orphan Drug Act was passed in 1983 to give drug companies incentives to develop treatments for rare diseases. India does not have laws on orphan drugs though CDSCO defined orphan drugs as those intended to treat a condition which affects fewer than 200,000 people.

NIT Rourkela is one of the premier national level institutions for technical education in the country and is funded by the Government of India. Government of India has elevated the Regional Engineering College, Rourkela to a deemed university under the name of National Institute of Technology, Rourkela.  The main objective of the Institute is to produce quality Engineers and Scientists in Graduate and Post-Graduate levels in various branches of Engineering and Science.

Post : Junior Research Fellow